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http:WHAT THIS PAPER ADDS
The use of three-dimensional ultrasound (3-D US) have not previously been applied in the clinical context of
vascular surgery.
We present a new 3-D US method for volume estimation of abdominal aortic aneurysms using a 3-D interactive
segmentation technique and a 3-D US matrix probe capable of acquiring large series of two-dimensional (2-D)
images faster than the previous mechanical scanners. This paper shows that 3-D US is a feasible, precise and
accurate method for volume estimation of the residual sac after endovascular aneurysm repair (EVAR) using 3-D
CT as the gold standard.Objectives: Volume estimation is more sensitive than diameter measurement for detection of aneurysm growth
after endovascular aneurysm repair (EVAR), but this has only been conﬁrmed on three-dimensional,
reconstructed computer tomography (3-D CT). The potential of 3-D ultrasound (3-D US) for volume estimation in
EVAR surveillance is unknown.
Design: Prospective validation study comparing 3-D US with 3-D CT, using 3-D CT as the gold standard.
Materials and methods: From August 2011 to March 2012, 93 consecutive EVAR patients were enrolled and
examined with both 3-D US and CT angiography (CTA). Image data were analysed in a mutual blinded setup using
a 3-D interactive segmentation technique.
Results: The technical success rate of 3D-US was 98% (91/93). In 91 EVAR patients (F/M; 10/81) eligible for
further analysis, the mean maximum volume (SD) was 126 (58) ml using 3-D US and 128 (58) ml using 3-D CT. The
mean difference was 1 ml (0.4%) and the limits of agreement were 14 to 16 ml (11; 12%).
Conclusion: Volume estimation of the aortic sac after EVAR using 3-D US is a feasible and accurate method using
3-D CT as the gold standard.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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surveillanceEndovascular aneurysm repair (EVAR) is associated with
a three to four times higher rate of re-intervention than
open surgery, and a risk of aneurysm-related death of 1%
per year emphasises the need for life-long postoperative
surveillance.1
The purpose of endovascular treatment is to remove the
arterial pressure from the aneurysm sac and thereby
prevent further expansion and potential rupture. Expansion
of the residual sac in spite of EVAR suggests the presence of
an endoleak, which in cases of type I or III must be treated.of original article: http://dx.doi.org/10.1016/j.ejvs.2013.01.024
responding author. Tel.: þ45 29 47 22 69; fax: þ45 35 45 31 11.
il address: kimbobank@yahoo.dk (K. Bredahl).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2012.12.018In the absence of an endoleak or in the presence of a type-II
leak, the clinical decision depends on how the size of the
aneurysm develops.2 Any effective EVAR surveillance
strategy must therefore include evaluation of the size of the
aneurysm sac. This evaluation is based primarily on
measurement of the maximum aneurysm diameter.
However, it has been argued that diameter change corre-
lates poorly with volumetric change after EVAR and data
supporting this argument have been reported from the
surveillance of small aneurysms.3,4
Measurement of the correct maximum aneurysm diam-
eter can be hindered by the morphology of the aneurysm or
by modiﬁcations of the residual sac after EVAR, which may
upset proper orientation and image plane. Shortcomings of
current evaluations based on two-dimensional (2-D)
imaging can be compensated for by three-dimensional (3-D)
K. Bredahl et al. 451imaging, which provides a better image-plane orientation
and volume assessment and yields more structural infor-
mation than 2-D imaging. A more effective EVAR surveil-
lance protocol based on computed tomography (CT)-
volume estimation instead of observation of the diameter
change of the residual sac has already been proposed.5
Three-dimensional ultrasound (3-D US) imaging evalu-
ating aortic aneurysm is a sparsely reported imaging
modality.6 3-D US imaging has previously been described in
other clinical settings: mechanical scanners and free-hand
techniques with and without position sensing.7 However,
use of 3-D US in these settings not only was found to be too
difﬁcult for daily clinical practice but also involved the use
of challenging software.8
The aims of the present study were to conduct a valida-
tion study comparing an improved 3-D US technique for
volume estimation of the residual sac after EVAR with 3-D
CT and to investigate the reproducibility of 3-D US.MATERIALS AND METHODS
Patients and study design
From August 2011 to March 2012, all patients treated for an
abdominal aortic aneurysm with EVAR and scheduled for
our standard EVAR surveillance consisting of 3- or 12-month
CT angiography (CTA) control were prospectively and
consecutively enrolled into the study. In order to stan-
dardise the population, patients with isolated iliac aneu-
rysms were not included in the study. All patients were
recruited from one centre, and all EVAR procedures were
performed using the same EVAR device (Zenith stent grafts,
Cook Medical Inc., Bloomington, IN, USA). Concurrent CT
and 3-D US examinations were performed and evaluated in
a mutual blinded setup.3-D US imaging
The patients did not routinely undergo any speciﬁc prepa-
rations, that is, fasting before the US scanning. After 10 min
of rest, the patients were placed in a supine position. One
operator (KB) with 4 years of experience in vascular US
performed all US investigations using an X6-1 matrix
transducer and a Phillips iU22 US system (Philips Medical
Systems, Bothell, WA, USA). The improvements of the X6-1
matrix transducer compared to the previous V6-2
mechanical transducer include the widened range of scan
ﬁeld and the electronic sweep technology making the
acquisition twice as fast. The standard for all US procedures
was to locate the maximum cross section of the residual sac
in both the transverse and the longitudinal scan plane using
the biplane imaging feature and to perform the entire 3-D
acquisition from this position. We did not use any other
anatomical references, that is, lumbar vertebrae. Assisted
by biplane imaging, the boundaries of the residual sac were
kept inside the scan ﬁeld. The 3-D US acquisition was per-
formed during breath hold without moving the transducer
and the electronic sweep was completed within approxi-
mately 1 s.To assess the 3-D US intra-operator variability, the ﬁrst 3-
D US acquisition was stored at the beginning of the
examination. The 3-D US matrix probe was then switched
off, and a standard US examination with contrast
(Sonovue, Bracco, Milan, Italy) using a curved 5-MHz
abdominal transducer (C5-1) was performed according to
the protocol.
The 3-D US matrix probe was subsequently switched on
again and a second 3-D acquisition was performed (KB). The
two 3-D acquisitions were then handled separately in the 3-
D interactive Philips software (see below) with at least 14
days of delay by the same operator (KB).
To assess the 3-D US inter-operator variability, a second
US operator (JE) with more than 15 years of vascular US
experience independently rescanned 20 patients, who were
selected by their concurrent presence on weekdays where
both operators (KB and JE) were available. The same
operator (JE) afterwards independently handled his own 3-
D acquisitions in the 3-D software.
Computed tomography
Biphasic acquisition (unenhanced and contrast-enhanced
with bolus tracking) was performed using a helical 64-slice
CT scanner (Toshiba Medical Systems Ltd., Crawley, UK).
Detector conﬁguration was 0.5  64 (collimation ¼ 32 mm)
with a pitch of 0.8. A bolus dose of 80 ml of non-ionic
iodinated contrast medium (Iohexol 350 mgI ml1,
Omnipague; GE Healthcare Denmark A/S, Copenhagen,
DK) was injected into an ante-cubital vein at a rate of
3 ml s1. Scan reconstructions were performed with a slice
thickness and increment of 3 mm.
To assess the 3-D CT inter-operator variability, all patients
(n ¼ 28) enrolled during the ﬁrst 3 months of the study
period had their CT scans assessed independently by two
operators (KB and AL) experienced in using the 3-D software
(see below). All other CT scans were evaluated by one
operator only (KB).
3-D reconstruction and volume estimation
Concurrent US and contrast-enhanced CT acquisitions were
handled in a 3-D interactive experimental software proto-
type (AAA_prototype, version 1.0, Medisys, Philips
Research, Suresnes, France) (Fig. 1A and B).
The residual sac including the stent graft on US and CT
acquisitions was semi-automatically delimited with the 3-D
interactive segmentation technique.9 We used the inner
vessel wall when determining the volume difference
between the US and CT acquisition and when estimating
the 3-D US reproducibility. The 3-D CT reproducibility was
estimated by using the outer, circumferential vessel wall.
When segmentation was completed, a centreline was
calculated using two manually deﬁned extremities at the
most proximal and distal locations (Fig. 1C). Planes
perpendicular to the centreline were then deﬁned at
regularly spaced positions along the centreline (Fig. 1D). For
each contour the area (mm2) was deﬁned. A partial volume
deﬁned by two contours placed 30 mm proximal and distal
Figure 1. (A) Segmentation process in cross-sectional view using
the green shape to “push and drag” the delineation. (B)
Segmentation process in longitudinal view. (C) Volume segmen-
tation completed, showing the automatically generated green
centreline between the manually deﬁned proximal and distal
extremities. (D) The principle used for volume calculation: The
pixels in the total scan ﬁeld subtracted the pixels outside the
segmentation equals the pixels inside the segmentation. Contours
are all perpendicular to the centreline and colour coded according
to size (blue: maximum contour).
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calculated. This gave a partial volume of the residual sac
with a total length of 60 mm. Due to decreased image
quality in the outer range of the acquisition, it would be
impossible to choose a longer distance in some patients.
Hence, the chosen length of 60 mm was a trade-off
between including as much of the aneurysms as possible
and having a standardised data set. In the case of an aorto-
iliac aneurysm only the abdominal component of the
aneurysm was included in the estimated volume.Figure 2. Bland Altman plot showing the difference in maximum
volume plotted against mean volume for paired observations.
SD ¼ standard deviation.STATISTICS
The maximum volumes of the 3-D US and the 3-D CT esti-
mations were compared using the BlandeAltman plot,
where the differences in concurrent measurements on the
same subject are plotted against the mean outcome,
showing the mean difference and the upper and lower
limits of agreements given by the mean  1.96  standard
deviation (SD).10 By calculating the standard error for the
upper and lower limits of agreement (SE ¼ O(3  SD2/N)),
absolute 95% conﬁdence intervals (CIs) were calculated for
these values. The variances of the observed differences in
inter-operator and intra-operator variability of 3-D US were
tested for homogeneity using Levene’s test. The reproduc-
ibility coefﬁcients were expressed as 1.96  SD.
As no consensus regarding the range of variability for
volume estimation exists, we created an ‘imaginary
cylinder’ with a length of 60 mm equivalent to the deﬁned
length of the partial volume measured.
For each patient’s partial-volume value, we calculated the
diameter of the ‘imaginary cylinder’ (r2  pl). We then
changed the diameter by 5 mm, which is the currentlyaccepted 2-D US inter-operator variability in aneurysm
diameter measurement, and we calculated a new volume
value.4,11 For example, at a measured partial-volume value
of 200 ml, the corresponding diameter of our ‘phantom
cylinder’ is 2  O(vol./(p  l)) ¼ 65 mm. Increasing the
diameter by 5 mm to 70 mm will yield a corresponding
volume of the new cylinder of r2  p  l ¼ (70 mm/
2)2  p  60 mm ¼ 232 ml. If the range of variability at
a partial-volume value of 200 ml exceeds 32 ml, the volume
variability will hence be larger than the presently accepted
variability in 2-D US diameter measurement. The volume-
variability range calculated for the presently accepted US
inter-operator variability of aneurysm-diameter measure-
ment is plotted in Fig. 3 (dotted curved lines).
All calculations were performed using Statistical Package
for the Social Sciences (SPSS) v. 18.01 (SPSS Inc., Chicago, IL,
USA). The local ethical committee approved the study (H-2-
2011-016) and informed consent was obtained from all
patients.RESULTS
Patients
From August 2011 to March 2012, 98 consecutive patients
were eligible for the study, but ﬁve patients had no residual
sac, which left 93 patients to be enrolled in the study. The
technical success rate of 3-D US was 98% (91/93) as two
patients had an inadequate US image quality (respiration
and bowel gas).
In the 91 patients (F/M; 10/81) who were eligible for
further analysis, the mean age was 74  14 years, the
average maximum aneurysm diameter was 5.7  2.0 cm
and the mean body mass index (BMI) was 26  7 kg m2.Volume estimation by 3-D-reconstructed CT versus 3-D US
The volume difference for concurrent 3-D CT and 3-D US
was determined and plotted against the mean. The mean
difference was 1 ml and the limits of agreement
were 14 ml (11%) to 17 (12%) (Fig. 2). The mean
maximum volume (SD) of 3-D US (127 ml (51)) was not
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3-D CT (128 ml (53)) (p ¼ 0.07).Reproducibility
The inter- and intra-operator reproducibility coefﬁcients of
3-D US were 17 ml (13%) and 16 ml (12%), respectively. The
upper limit of agreement for the 3-D US inter-operator
variability was 19 ml (95% CI: 12e25) and the lower limit of
agreement was 14 ml (95% CI: 7 to 21). The corre-
sponding upper and lower limits of agreement for the 3-D
US intra-operator variability were 17 ml (95% CI: 10e23)
and 15 ml (95% CI: 8 to 21), respectively. No statisti-
cally signiﬁcant difference was seen between the inter- and
the intra-operator variability (p ¼ 0.94).
The inter-operator reproducibility coefﬁcient of 3-D CTwas
9ml (7%).The upper and lower limits of agreement for 3-D CT
were 7 (4e10) and 11 (8 to 14), respectively (Fig. 3).
DISCUSSION
Our study showed that post-EVAR volume estimation of the
residual sac can be made reliably by 3-D US. The results
obtained with this technique are comparable to those of 3-
D CT within a range of 12%.
Observation of volume change has currently only been
possible using CTA, which also has a high diagnostic value in
detecting endoleaks.2 Contrast-enhanced CTA scan is
therefore the most-used imaging modality for EVAR
surveillance, even if it has signiﬁcant drawbacks such as
a risk of contrast-induced nephropathy, radiation and costs.
In contrast, US is harmless, cheaper and provides an
immediate diagnosis that allows the patient’s symptoms to
be interpreted on the spot and the patient to be informed
about his or her diagnosis at the same time.
Some of the drawbacks associated with the present US
technique are that it relies on the operator’s proﬁciency and
the patient’s BMI and bowel movements and the uncer-
tainty that characterises maximum diameter measure-
ments.11 Furthermore, US is not considered the reference
image modality for follow-up after EVAR.Figure 3. Reproducibility. Dotted curved lines: For every volume value,
with a length of 60 mm. The diameter was then changed 5 mm and
volume variability to the current accepted diameter variability. The
corresponding to the calculated diameter þ5 mm and the lower dotted
the calculated diameter 5 mm. For more information, see text e StIt is important to note that a calculation of a volume
change in per cent of 3-D structures yields a larger ﬁgure
than the equivalent percentage change in diameter, that is,
if a 6-cm-long cylinder with a diameter of 5.5 cm grows to
5.8 cm, the diameter increase is approximately 5%, but the
volume doubles by more than 10%.
Although the reproducibility coefﬁcient was higher for 3-
D US (17 ml) than for 3-D CT (9 ml), the 3-D US inter-
operator variability remained within the range of the
volume variability that we estimated on the basis of the
presently accepted diameter variability during the screening
procedures (see Statistical Section). Furthermore, the 3-D
CT inter-operator variability included only the reading
process, whereas the 3-D US inter-operator variability
included both a new acquisition and a reading. The absolute
3-D CT inter-operator reproducibility coefﬁcient of 9 ml in
our study was comparable to that (10 ml) reported by
Wever et al.12
The US image quality was the most important reason why
the reproducibility was greater in 3-D US than in 3-D CT. The
X6-1 transducer yielded a slightly poorer image quality than
the conventional 2-D curved-array transducer, and espe-
cially the posterior wall had a reduced signal-to-noise ratio.
First, the discrimination between the caval vein and the
aorta was at times impaired. Second, it could be difﬁcult to
encompass large aneurysms in thin patients within the scan
ﬁeld, which hampered delineation of the most proximal and
distal parts of the aneurysm. Third, differentiation between
the stent graft and the inner vessel wall was difﬁcult in
certain cases, especially when the residual sac was small
and the two structures were located close to each other.
Finally, in contrast to 3-D CT where volume measurement
can be made at ﬁxed points, that is, from the lowest renal
artery to the aortic bifurcation, 3-D US volume estimation
was based on the position of the maximum cross section. If
remodelling occurs, the longitudinal position of the
maximum cross section may change and give rise to altered
volume estimation. How this affects the use of the tech-
nique for serial volume measurements is a matter for future
research.we calculated the diameter of an “imaginary cylinder” (r2  p  l)
we re-calculated new volume values, representing the equivalent
upper dotted curved line represents the volume of the cylinder
curved line represents the volume of the cylinder corresponding to
atistics, SD ¼ standard deviation.
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the very few confounders that could inﬂuence the study
result. For example, all scans were performed by the same US
operator using the same US equipment, all CT scans were
performed according to the same protocol, the recruitment
period was short, sufﬁciently many patients were recruited
to ensure heterogeneity in terms of aneurysm morphology
and size and, ﬁnally, all patients were treated at the same
institution with implantation of the same EVAR device. In
general, we do not consider the choice of the EVAR device to
be a limiting factor for the US examination; however, we have
experienced that graft material containing air (e.g., poly-
tetraﬂuoroethylene (PTFE)) could make the US examination
impossible within the ﬁrst days of implantation. This was,
however, not a problem in this study with US examination at
the earliest 3 months post EVAR.
The technical success rate was high. The 3-D images are
generated from a high number of frames that to some
extent will compensate for suboptimal 2-D image, that is,
due to bowel gas. The high technical success rate can also
be explained by the research setting allowing us more time
for challenging patients. Thus, as the results were produced
in a research setting and the same US operator performed
all US procedures, we recognise that our results can be
difﬁcult to duplicate in routine practice.
We acknowledge this novel modality have many chal-
lenges yet to overcome. First, the manual segmentation
process adds approximately 15e30 min to the US exami-
nation. Second, the scientiﬁc and clinical reasons for
observing volume instead of diameter in EVAR surveillance
are yet not well established although CT volume estimation
is shown to be more sensitive to growth than diameter.3
Whether any clinically important beneﬁt from serial volume
assessment after EVAR beyond simple measurement of
maximal aneurysm diameter may be obtained remains
controversial.3,5,13 Third, the level of US skills in the
outpatient clinic is of course a critical issue. It is important
to realise that both 3-D US and 3-D CT are composed of
three parts: acquisition, reconstruction and analysis. The CT
acquisitions are performed by technicians and the recon-
structions are generally also performed by trained techni-
cians or, in cases of difﬁcult patients, by medical doctors,
depending on the organisation. The CT analysis, however,
requires a doctor. Parallel to that, the common 2-D US
acquisitions and analysis are performed by trained techni-
cians (or surgeons, radiologist or other specialists)
depending on local organisation and national traditions. In
the future, and in medical centres where common US
procedures are performed by technicians, trained techni-
cians will be able to perform the 3-D acquisitions. As
regards the 3-D US reconstruction, we believe that further
software development and further automation of the
reconstruction process will allow these trained technicians
to perform the reconstruction in uncomplicated cases.
Difﬁcult patients will probably still require involvement of
a doctor, be it a surgeon, radiologist or angiologist. The 3-D
technique itself is not a particularly complex procedure
compared to the common EVAR 2-D US surveillance scan,which we considered to be a demanding examination. On
the other hand, as the 3D-US technique is still new and the
software is a prototype, acquisition, sequence analysis and
reconstruction have been performed by experts in order to
validate it and to compare it to CT.
In our institution, abdominal aortic aneurysm-volume
estimation is still reserved for research. Before eventual
implementation of this new technique in routine practice, we
need to take the additional time needed, cost of equipment
and the slightly more cumbersome technique into consider-
ation. Nevertheless, we expect that 3-D US could be imple-
mented routinely, and as future progress in automatic
segmentation is ongoing, we may expect not only a faster
segmentation process but also improved reproducibility. We
foresee that this novel technique combined with contrast-
enhanced US for endoleak detection has the potential to
challenge and replace the diagnostic possibilities that CT
currently provides for EVAR surveillance and, in contrast to CT,
US also provides unique haemodynamic information. This
new regime will reduce the radiation dose given to patients
and avoid the risk of contrast-induced nephropathy. Although
no medico-economic analysis has been made we believe that
in our department, already having high-end US scanners and
experienced personnel, US has the potential to decrease the
overall expenses for EVAR surveillance. Nevertheless, in order
to foresee the costs of the consequences on the patient care
with the two models of follow-up a dedicated prospective
medico-economic study has to be conducted. By continuing
our 3-D project, we hope to clarify whether volumetric
changes and information concerning structural properties
could add more predictive value to the present surveillance
strategy for EVAR.
Regarding small asymptomatic aneurysms we still ﬁnd
the maximum aneurysm diameter to be the strongest
predictor of rupture14,15 and the reference for intervention.
We are, nevertheless, encouraged also to apply 3-D US in
the surveillance of small asymptomatic aneurysms. This
novel technique offers the possibility to perform studies
evaluating structural information and volumetric change
compared to diameter change and most importantly, this
accurate technique is harmless and will therefore allow
natural history studies of large scale. We recognise that our
results may not be directly transmittable to small aneurysm
surveillance, but the absence of a stent device will probably
improve imaging of the posterior wall and even better
results can be expected.
In conclusion, volume estimation of the aortic sac after
EVAR using 3-D US can be performed quickly and accurately
with a high technical success using 3-D CT as the gold
standard. Besides the volume estimation, unique haemo-
dynamic information can be included in a one-step proce-
dure. US volume estimation of the aortic sac is a promising
tool for the future EVAR surveillance.ACKNOWLEDGEMENTS
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